Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 8,020,136 | 8,020,136 | 0 | $227.69M | $283.03M | 29.80% | +$55.34M |
| Kymera Therapeutics, Inc.(KYMR) | 5,377,362 | 5,350,422 | -26,940 | $216.17M | $159.71M | 16.82% | -$56.46M |
| Third Harmonic Bio, Inc. | 10,907,859 | 10,907,859 | 0 | $102.97M | $141.80M | 14.93% | +$38.83M |
| Disc Medicine, Inc.(IRON) | 2,287,233 | 2,509,456 | +222,223 | $142.40M | $113.10M | 11.91% | -$29.30M |
| Day One Biopharmaceuticals, Inc. COM | 6,430,257 | 6,430,257 | 0 | $106.23M | $88.61M | 9.33% | -$17.62M |
| Korro Bio, Inc.(KRRO) | 1,119,292 | 1,137,149 | +17,857 | $100.74M | $38.52M | 4.06% | -$62.22M |
| Q32 Bio Inc.(QTTB) | 2,092,106 | 2,092,106 | 0 | $35.65M | $37.55M | 3.95% | +$1.90M |
| Generation Bio, Co. | 8,279,484 | 8,279,484 | 0 | $33.70M | $23.35M | 2.46% | -$10.35M |
| Vigil Neuroscience, Inc. | 5,836,874 | 5,836,874 | 0 | $19.90M | $23.35M | 2.46% | +$3.44M |
| Replimune Group, Inc.(REPL) | 2,098,300 | 2,098,300 | 0 | $17.14M | $18.88M | 1.99% | +$1.74M |
| Ikena Oncology, Inc. | 5,018,178 | 5,018,178 | 0 | $7.13M | $8.28M | 0.87% | +$1.15M |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 378,447 | +378,447 | $0 | $6.23M | 0.66% | +$6.23M |
| Dianthus Therapeutics, Inc.(DNTH) | 186,979 | 136,979 | -50,000 | $5.61M | $3.55M | 0.37% | -$2.06M |
| Aerovate Therapeutics, Inc. | 2,039,249 | 1,799,232 | -240,017 | $60.30M | $2.99M | 0.31% | -$57.31M |
| Spero Therapeutics, Inc.(SPRO) | 607,613 | 535,336 | -72,277 | $1.05M | $695.9K | 0.07% | -$349.2K |
| AvroBio, Inc. | 4,541,381 | 0 | -4,541,381 | $5.81M | $0 | — | -$5.81M |
| Xilio Therapeutics, Inc.(XLO) | 992,912 | 0 | -992,912 | $1.07M | $0 | — | -$1.07M |